BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9233423)

  • 1. Gene transfer of suicide genes for the treatment of malignant gliomas: efficacy, limitations, and perspectives for a combined immunotherapy.
    Benedetti S; Di Meco F; Pollo B; Bruzzone MG; Cirenei N; Spreafico R; Solero CL; Broggi G; Di Donato S; Finocchiaro G
    Acta Neurochir Suppl; 1997; 68():100-4. PubMed ID: 9233423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
    Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives for the gene therapy of malignant gliomas by suicide gene transfer.
    Di Meco F; Benedetti S; Colombo MP; Finocchiaro G
    J Neurosurg Sci; 1997 Sep; 41(3):227-34. PubMed ID: 9444575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
    Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bystander tumoricidal effect in the treatment of experimental brain tumors.
    Wu JK; Cano WG; Meylaerts SA; Qi P; Vrionis F; Cherington V
    Neurosurgery; 1994 Dec; 35(6):1094-102; discussion 1102-3. PubMed ID: 7885554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
    J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
    Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
    BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor effect of suicide gene therapy using Bifidobacterium infantis-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma.
    Xiao X; Jin R; Li J; Bei Y; Wei T
    Urology; 2014 Oct; 84(4):982.e15-20. PubMed ID: 25123427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
    Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.
    Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Franchin E; Del Vecchio C; Giaretta I; Boscaro M; Palù G
    Eur J Endocrinol; 2003 Jan; 148(1):73-80. PubMed ID: 12534360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirus-mediated transfer of the suicide gene into retinal pigment epithelial cells in vitro.
    Schubert CA; Kimura H; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ
    Curr Eye Res; 1997 Jul; 16(7):656-62. PubMed ID: 9222082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
    Ramesh R; Munshi A; Marrogi AJ; Freeman SM
    Int J Cancer; 1999 Jan; 80(3):380-6. PubMed ID: 9935178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
    Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
    Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.
    Couderc BC; de Neuville S; Douin-Echinard V; Serres B; Manenti S; Darbon JM; Malecaze F
    Curr Eye Res; 1999 Dec; 19(6):472-82. PubMed ID: 10550788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.